India’s revised Uniform Code for Pharmaceutical Marketing Practices (UCPMP) has widened disclosure requirements for industry’s interactions with healthcare professionals and laid down a framework for continuing medical education (CME) programs that includes enabling provisions for an audit of these initiatives.
While the conduct of CMEs and continuing professional development (CPD) programs at “foreign locations” has been barred, UCPMP 2024 requires...







